Calton & Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
SAM
AIM
GI
PWAM
DRZID
Calton & Associates's DBD Position: Q1 2018 in Review
Calton & Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2018, closing a stake of 225 shares — an estimated $4K sold.
Calton & Associates first reported a position in DBD in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 246 funds tracked by Wall St. Rank hold DBD as of Q1 2018.
- Calton & Associates reported no remaining Diebold Nixdorf Incorporated position as of Q1 2018 after selling out during the quarter.
- Calton & Associates sold 225 Diebold Nixdorf Incorporated shares in Q1 2018, an estimated $4K.
- Calton & Associates first reported a position in Diebold Nixdorf Incorporated in Q4 2017 and held it in 1 quarter.
- Calton & Associates's Diebold Nixdorf Incorporated position peaked at $4K in Q4 2017.
- 246 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2018.
Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.